ONCOCROSS

ONCOCROSS
Technology
Collaboration
News/IR

CONTACT US

한

ONCOCROSS
Technology
Collaboration
News/IR

한
EN

CONTACT US

Main
News/IR
Regulatory Disclosure

Regulatory Disclosure

35 Posts

Report on Major Issues(Decision on Merger)

04-15-2026
Report on the Grant of Stock Options

04-09-2026
Outcomes of Annual Meeting of Shareholders

03-27-2026
Report on the Grant of Stock Options

03-27-2026
Report on the Appointment, Dismissal or Early Retirement of Outside Directors

03-27-2026
Submission of Audit Report

03-19-2026
Annual Report

03-19-2026
Resolutions for Convocation of General Meeting of Shareholders

03-05-2026
Reporting reasons for holding general shareholders' meeting on the most concentrated date

03-05-2026
Reference Documents for Proxy Solicitation

03-05-2026
Announcement of Convocation of General Meeting of Shareholders

03-05-2026
30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations)

02-10-2026

1
2
3

Please enter a prompt

CEO: Yi Rang KIM / Jihoon KANG

Address: #905 7 Beobwon-ro 11-gil, Songpa-gu, Seoul, 05836, Korea

Tel: 02-717-9967

Fax: 02-867-9968

Email: oncocross@oncocross.com

Terms & Conditions Privacy Policy Cookie Policy

ⓒ ONCOCROSS CO., LTD. All Rights Reserved.